General issues related to drug research and innovation; issues related to the Congressional Plasma Caucus.
2025 · 2nd Quarter (Apr 1 - June 30)
TAKEDA PHARMACEUTICALS AMERICA, INC.
Filed by PORTERFIELD, FETTIG & SEARS, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 18, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- PORTERFIELD, FETTIG & SEARS, LLC
- Filing UUID
- 22f93edf-0fd8-46bc-93d8-6892821d2a2c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to global taxes, specifically Section 899 of H.R. 1.
Literal federal measure citations: H.R. 1
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.